Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis

BMC Endocrine Disorders

Table 2 Showed the characteristics of the included studies

Author	Year of study	Year of publication	Type of study	Mean age	Proportion of female	Region	Type of DM	Screening technique	Total	Cases	Prevalence	Quality/10
Nielson et al. [31]	1996	1998	Cross sectional	50*	38*(of dn pat)	Riyadh	T₂	Clinical	375	143	38.1	7
Akbar et al. [32]	1999	2000	Cross sectional	54.19	NA	Jeddah	T₁ + T₂	MNSI	237	132	55.7	6
Akbar et al. [32]	1999	2000	Cross sectional	54.19	NA	Jeddah	T₁ + T₂	NCS	237	58	24.4	6
Mojaddidi et al. [40]	2009	2011	Prospective	51.79	54.3	Al-Madinah	T₁ + T₂	DNS + DNI	263	165	62.7	9
Mojaddidi et al. [40]	2009	2011	Prospective	51.79	54.3	Al-Madinah	T₁ + T₂	NCS	263	43	16.4	9
Halawa et al. [8]	2007	2010	Cross sectional	52.10	33.4	Multicentre	T₁ + T₂	DN4	1039	619	59.6	9
Ahmed et al. [33]	2012	2014	Cross sectional	51.43	43.0	Jeddah	T₂	Standardized assesment form	350	168	48.0	5
Wang et al. [34]	2010	2014	Cross sectional	59.50	38.2	Jeddah	T₁ + T₂	Clinical	552	110	19.9	8
Kasim et al. [35]	2012	2015	Cross sectional	51.50	58.0	Al-Madinah	T₁ + T₂	MDNS	100	20	20.0	7
Shesha et al. [36]	2013	2017	Cross sectional	45.40	41.5	Riyadh	T₂	NSS/NDS	125	44	35.2	8
Shesha et al. [36]	2013	2017	Cross sectional	45.40	41.5	Riyadh	T₂	NCS	87	34	39.1	8
Algeffari et al. [24]	2013	2018	Cross sectional	56.90	66.7	Riyadh	T₂	MNSI	242	84	34.7	8
Aljehani [37]	2019	2019	Cross sectional	50.62	62.7	Riyadh	T₁ + T₂	Clinical	469	324	69.1	8
Sendi at al. [38]	2019*	2020	Cross sectional	NA	54.7	Al-Madinah	T₁ + T₂	DN4	430	129	30.0	7
Almohaysen et al. [39]	NA	2020	Cross sectional	53.61	54.0	Al-Qassim	T₂	MDNS	374	143	38.2	8

*T₁:Type-1DM, T₂:Type-2DM,NCS: Nerve conduction study, MNSI: Michigan Neuropathy Screening Instrument, MDNS: Michigan Diabetic Neuropathy Score, DN4: DN4 assessment tool, NSS: Neurological symptom score, NDS: Neuropathy Disability Score

ISSN: 1472-6823